Assay devices with mobile control reagents

• US 6,686,170 B1
• Filed: 08/17/1994
• Issued: 02/03/2004
• Est. Priority Date: 08/17/1994
• Status: Active Grant

• Current Assignee: Abbott Laboratories Incorporated
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Varitek, Vincent A. Jr., Flanders, Richard T.
• Primary Examiner(s): EYLER, YVONNE L
• Application Number:
  US08/292,157
• Time in Patent Office: 3,457 Days
• Field of Search: 422/55, 422/56, 422/57, 422/61, 422/119, 435/4, 435/7.1, 435/7.34, 435/7.9, 435/7.92, 435/7.93, 435/7.94, 435/7.95, 435/805, 435/806, 435/810, 435/962, 435/967, 435/970, 435/971, 436/510, 436/514, 436/518, 436/523, 436/528, 436/531, 436/533, 436/534, 436/8, 436/60, 436/163, 436/810, 436/814, 436/906
• US Class Current: 435/7.34
• CPC Class Codes: G01N 33/558 using diffusion or migration of antigen or antibody immunochromatographic test strips G01N33/54387
• CPC Class Codes: G01N 33/56944 Streptococcus
• CPC Class Codes: G01N 33/76 Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
• CPC Class Codes: Y10S 435/962 Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
• CPC Class Codes: Y10S 435/967 Standards, controls, materials, e.g. validation studies, buffer systems
• CPC Class Codes: Y10T 436/10 Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Abstract

The present invention relates to an improved immunoassay device for confirming the validity of a test result showing either the presence or absence of an analyte in a patient sample. In the improved device, control reagents are provided in the device which directly mimic the reaction of the sample analyte with the test reagents of the device. The device thus allows the user to verify the efficacy of the test reagents at all stages of interaction with the sample analyte.

Claims

1. In an analytical device for determining the presence or amount of an analyte in a test sample, having a strip with a proximal end and a distal end, wherein the test sample can travel from said proximal end to about said distal end by capillary action, and wherein said strip contains an immobilized patient capture reagent which binds to a member selected from the group consisting of the analyte, an ancillary specific binding member and a labeled reagent,

the improvement comprising:

a) a mobile positive control reagent;

b) an immobilized positive control capture reagent that is located at a site downstream from the mobile positive control reagent and is capable of binding the mobile positive control reagent.

2. The device according to claim 1, wherein the mobile positive control reagent is human chorionic gonadotropin or Group A Streptococcus polysaccharide.

3. The device according to claim 1, wherein said immobilized positive control capture reagent is configured as a letter, number, icon, or symbol.

4. The device according to claim 3 wherein the immobilized positive control capture reagent is located adjacent the immobilized patient capture reagent.

5. The device according to claim 1, further comprising an immobilized negative control reagent used to determine the presence of non-specific binding or aggregation of any labeled reagent in the device.

6. The device according to claim 5, wherein the immobilized negative control reagent is non-immune antibody prepared from the same or a different animal source as the patient capture reagent.

7. The device according to claim 5 wherein the negative control reagent is located adjacent the immobilized patient capture reagent.

8. The device according to claim 7 wherein the negative control reagent is configured as a letter, number, icon, or symbol.

9. The device according to claim 1, wherein a labeled reagent is contained within the strip in a situs between the proximal end and the immobilized patient capture reagent.

10. The device according to claim 9, wherein the positive control capture reagent is an immobilized anti-Group A Streptococcus antibody and the labeled reagent is a labeled anti-Group A Streptococcus antibody.

11. The device according to claim 9, wherein the positive control capture reagent is an immobilized anti-human chorionic gonadotropin antibody and the labeled reagent is a labeled anti-human chorionic gonadotropin antibody.

12. A kit for use in specific binding assays, having an analytical device for determining the presence or amount of an analyte in a test sample, comprising a strip having a proximal end and a distal end, wherein the test sample can travel from said proximal end to about said distal end by capillary action, and wherein said strip contains an immobilized patient capture reagent which binds to a member selected from the group consisting of the analyte, an ancillary specific binding member and a labeled reagent,

the improvement comprising:

a) a mobile positive control reagent;

b) an immobilized positive control capture reagent that is located at a site downstream from the mobile positive control reagent and is capable of binding the mobile positive control reagent.

13. The kit according to claim 12, further comprising an immobilized negative control reagent used to determine the presence of non-specific binding or aggregation of any labeled reagent in the device.